The Maxillofacial Center for Diagnostics & Research
Table 11a: Relative frequency of oral verrucous carcinoma
compared to all head & neck carcinomas.
Table 11b: Incidence of oral verrucous
carcinoma & other H&N carcinomas in Rochester, Minnesota.
Table 11c: Age-specific iIncidence
of oral verrucous carcinoma in the state of West Virginia.
Table 11d: Listing of literature references pertaining
to verrucous carcinoma.
Diagnosis |
Number of Lesions |
||||
| Lip
Vermilion |
Intraoral
Mucosa |
Pharyngeal
Mucosa |
Laryngeal
Mucosa |
|
|
| Squamous cell carcinoma | 65 | 50 | 46 | 49 | 210 |
| Carcinoma in situ | 15 | 8 | 5 | 7 | 35 |
| Microinvasive squamous cell carc. | 7 | 6 | 3 | 3 | 19 |
| Metastatic carcinoma to the UAT | 0 | 4 | 2 | 0 | 6 |
| Adenocarcinoma (minor glands) | 1 | 2 | 4 | 0 | 7 |
| Verrucous carcinoma | 0 | 2 | 0 | 0 | 2 |
| Lymphoepithelioma | 0 | 1 | 7 | 0 | 8 |
| Basal cell carcinoma | 10 | 0 | 0 | 0 | 10 |
| Total * | 98 | 73 | 67 | 59 | 297 |
* no primary cases were found of malignant melanoma, spindle cell carcinoma, basaloid squamous carcinoma, or adenosquamous carcinoma
[ Return to main Table 11: Epidemiology of Verrucous Carcinoma ]
|
# Cases/100,000 person-years * | |||
| Males | Females | Total | ||
| Lip vermilion | 8.2 (74)** | 0.8 (9) ** | 4.1 (83)** | |
| Intraoral mucosa | 5.4 (38) | 2.1 (23) | 3.6 (61) | |
| Verrucous carcinoma (oral) | 0.2 (2) | 0.0 (0) | 0.1 (2) | |
| Pharyngeal mucosa | 5.2 (38) | 2.0 (22) | 3.4 (60) | |
| Laryngeal mucosa | 7.0 (49) | 0.3 (3) | 3.3 (52) | |
| Nasal/Paranasal sinuses | 0.7 (6) | 0.6 (6) | 0.7 (12) | |
| Major salivary glands | 1.1 (11) | 1.3 (13) | 1.3 (24) | |
| All primary carcinomas | 30.0 (216) | 7.2 (76) | 17.3 (292) | |
* population base: 900,312
person-years for males, 1,102,916 person-years for females
** numbers in parentheses represent actual number of cases, not incidence
rates; carcinomas
in situ and metastases
to the upper aerodigestive tract are excluded from the above data
Age |
# Cases | # Cases/100,000 person-years |
| 0-24 years | 0 | 0.00 |
| 25-34 years | 1 | 0.14 |
| 35-44years | 1 | 0.12 |
| 45-54 years | 0 | 0.00 |
| 55-64 years | 4 | 0.76 |
| 65-74 years | 4 | 0.84 |
| 75+ years | 7 | 1.95 |
| Total: | 17 | 0.28 * |
* age-adjusted to the 1970 U.S. white population
[ Return to main Table 11: Epidemiology of Verrucous Carcinoma ]
McCoy JM, Waldron CA. Verrucous carcinoma of the oral cavity: a review of forty-nine cases. Oral Surg Oral Med Oral Pathol 1981; 52:623-629.
Medina JE, Dichtel W, Luna MA. Verrucous-squamous carcinomas of the oral cavity: a clinicopathologic study of 104 cases. Arch Otolaryngol 1984; 110:437-440.
Tornes K, et al. Oral verrucous carcinoma. Int J Oral Surg 1985; 14:485-492.
Kamath VV, et al. Oral verrucous carcinoma: an analysis of 37 cases. J Craniomaxillofac Surg 1989; 17:309-314.
Luna MA, Tortoledo ME. Verrucous carcinoma. In: Gnepp DR. ed. Pathology of the Head and Neck. London: Churchill Livingstone Inc, 1988:497-515.
Neville, BW, Damm DD, Allen CM et al. Oral and maxillofacial pathology. Philadelphia: W.B. Saunders; 1995:304-306.
Odell EW, Morgan R. Biopsy pathology of the oral tissues. London: Chapman & Hall Medical, 1998:229-233.
Turner JE, Hodge SJ, Callen JP. Verrucous carcinoma in a renal transplant patient after long term immunosuppression. Arch Dermatol 1980; 116:1074-1076.
Fisker AV, Philipsen HP. Verrucous hyperplasia and verrucous carcinoma of the rat oral mucosa. Experimental carcinogenesis using 4-nitroguinoline 1-oxide. Acta Pathol Microbiol Immunol Scand 1984; 92A:437-445.
Eisenberg E, Rosenberg B, Krutchkoff DJ. Verrucous carcinoma: a possible viral pathogenesis. Oral Surg Oral Med Oral Pathol 1985; 59:52-57.
Shroyer KR, Greer RO, Frankhouser CA, et al. Detection of human papillomavirus DNA in oral verrucous carcinomas by polymerase chain reaction. Mod Pathol 1993; 6:669-672.
Kahn MA, Dockter ME, Hermann-Petrin JM. Proliferative verrucous leukoplakia. Four cases with flow cytometry analysis. Oral Surg Oral Med Oral Pathol 1994; 78:469-475.
Murrah VA, Batsakis JG. Proliferative verrucous leukoplakia and verrucous hyperplasia. Ann Otol Rhinol Laryngol 1994; 103:660-663.
Bouquot JE. Epidemiology. In: Gnepp DR (ed). Pathology of the head and neck. Philadelphia, Churchill-Livingstone; 1988: 263-314.
Bouquot JE, Kurland LT. Weiland LH. Incidence of oral verrucous carcinoma in a U.S. community with minimal smokeless tobacco consumption. J Oral Pathol Med 1996; 25:271.
Bouquot JE. Oral verrucous carcinoma in two U.S. populations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86:________.
[ Return to main Table 11: Epidemiology of Verrucous Carcinoma ]